STEAP4 and obesity disorder: Additionally, various studies have shown that dysregulation of STAMP2 is associated with metabolic and inflammatory diseases, such as obesity [8,9,10], rheumatoid arthritis [11,12,13,14], and atherosclerosis [15,16].